NEW YORK (GenomeWeb News) - Molecular diagnostics startup Linkage Biosciences said yesterday that it has landed an undisclosed amount of seed financing, bringing its total funding to $1 million.
 
The financing was led by Greenhouse Capital Ventures, the company said.
 
Linkage, based in San Francisco, said it will use the funds to develop its line of genetic tests for solid organ and stem cell transplantation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.